Navigation Links
Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund
Date:7/17/2008

arried out in this field. We've been impressed by Arbel's achievements, including FDA approval, and are certain that Giza's global connections, experience and capabilities in the field of medical equipment will help the company fulfill its business vision.

We welcome Docor International joining the group of investors and the board of Directors, and are sure that they will make a great contribution to the Company."

Dr Alon Dumanis, CEO of Docor International, says: "After examining the company's capabilities and the market potential, it is our impression that Arbel's product is based on a ground-breaking technology that has already created considerable interest in the medical community. We are delighted to add Arbel Medical to Docor's portfolio, and intend to help the company meet its business goals with our experience and know-how in the field of life sciences."

About Arbel Medical

Arbel Medical, established in 2006, is active in the field of minimal-invasive treatments. The company is developing next generation medical devices for removing tumors by freezing (cryotherapy).

Among Arbel Medical's investors are Giza Venture Capital, which led the last capital raising round, the Ofer High Tech Group, the US-based Bridge Investment Fund, Docor International, TRD and Fattal.

About Docor International B.V

A leading investment group, Docor International B.V is part of the Van Leer Group Foundation. Docor invests in advanced technology-based companies with an Israeli presence, that make a significant contribution to the local economy. It focuses on companies in the life sciences, information technology and on industrial sectors with innovative technologies.

About Giza Venture Capital

Giza Venture Capital was established in 1992 and was one of the first Israeli investors specializing in early stage and seed investment. Giza manages around $500 million in four funds, and has invested in 87 companies with 32 exits
'/>"/>

SOURCE Arbel Medical
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
2. Saving Certified Continuing Medical Education (CME)
3. ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
4. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
5. RADI Medical Systems Launches Next Generation PressureWire(R) Certus
6. BioElectronics ActiPatch(TM) Product Chosen as One of 9 Medical Breakthroughs That May Change Your Life
7. Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
8. Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributors Association
9. Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition
10. Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point
11. Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Decision Resources, one of the ... and healthcare issues, finds that, according to responses ... Abbott,s briakinumab (both interleukin inhibitors) will capture 22 ... the drug market for moderate to severe psoriasis. ... uptake, capturing nearly three times as much patient ...
(Date:12/16/2009)... SAN DIEGO, Dec. 16 Sequenom, Inc. ... of Dr. Kenneth Buechler and Mr. David Pendarvis ... http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) ,, Kenneth F. Buechler, ... of Biosite Incorporated. From 1988 to 1994, Dr. ... forming Biosite, Dr. Buechler was a senior research ...
(Date:12/16/2009)... for the ultimate CHO cell culture supplement? InVitria has what ... cell culture media supplement that improves the growth and productivity ... culture performance, Zap-CHO is an animal free, well defined and ... ... Fort Collins, CO (PRWEB) December 16, 2009 -- Scientists working ...
(Date:12/16/2009)... A has been found to be effectinve in improving yelds of ... ... Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for ... by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... HSP-A has been found to be especially effective in improving yields ...
Breaking Biology Technology:In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2
... the 20th Anniversary of the Draper Prize, Draper Laboratory, in conjunction ... website for students and adults to learn about the impact engineers ... of the 32 engineers who have been awarded "Engineering,s Nobel" since ... ...
... (NTI(R)) (Nasdaq: NTII ) today announced financial ... 31, 2008. Revenues for the second quarter of fiscal ... the second quarter of fiscal 2008. Research and development ... December 31, 2008 compared to $7.4 million for the ...
... VIEW, Calif., Feb. 12 iZumi Bio, Inc., announced,today ... Officer and a,member of the company,s Board of Directors. ... Novacea, Inc. which merged with Transcept Pharmaceuticals,Inc. in January ... ) , iZumi Bio is ...
Other Biology Technology:New Educational Website Celebrates the Accomplishments of Engineers 2Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results 4iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer 2
(Date:12/17/2009)... headed for another mass extinction like the previous five, each ... species on the planet, then North American mammals are one-fifth ... California, Berkeley, and Pennsylvania State University analysis. , Many scientists ... degradation both the result of human activity ... "Big Five" that have occurred over the past 450 million ...
(Date:12/17/2009)... possible to use therapeutic vaccines to create both cheap ... One problem in developing such vaccines has previously been ... effective. However, there has now been a major breakthrough ... Uppsala University, is published in the December issue of ... treatment methods that are developed today for allergies, cancer, ...
(Date:12/16/2009)... Calif., Dec. 17 IBM ( ... America Inc. today announced a new security ... from Fujitsu with IBM,s leading enterprise single ... ) ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO ... help companies bypass the hassles of managing ...
Breaking Biology News(10 mins):Study shows loss of 15-42 percent of mammals in North America 2Study shows loss of 15-42 percent of mammals in North America 3Major breakthrough may pave the way for therapeutic vaccines 2Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 2Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 3Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 4Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 5STAAR Surgical Receives Japanese Clearance for the KS Ni Preloaded IOL Injector System 49159 1STAAR Surgical Receives Japanese Clearance for the KS Ni Preloaded IOL Injector System 49159 2STAAR Surgical Receives Japanese Clearance for the KS Ni Preloaded IOL Injector System 49159 3PAREXEL International to Present at the Wachovia Equity Conference 12667 1PAREXEL International to Present at the Wachovia Equity Conference 12667 2BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 1BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 2BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 3
... seeing is believing: Evaluating a patients response to ... interpretation of scans of cancer tumors. Researchers have ... the reduction of metabolic activity after chemotherapy first ... chemotherapy, according to a study in the October ...
... Amur leopard (Panthera pardus orientalis), one of only an ... and health-checked by experts from a consortium of conservation ... of organizations, including the Russian Academy of Sciences Institute ... and the Zoological Society of London (ZSL) captured the ...
... announced today the selection of 18 of Europes most ... prestigious Young Investigator Programme. , Each year since 2000, ... in Europe. Recipients receive academic, practical and financial support ... careers. , Selected by EMBO Members for the ...
Other Biology News:Quantitative PET imaging finds early determination of effectiveness of cancer treatment 2Critically endangered Amur leopard captured 218 young scientists join EMBO Young Investigator network 2
Carrier Serum...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
Biology Products: